Telix Pharmaceuticals Limited

TLX ·Healthcare, Drug Manufacturers - General, Australia
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Sep 14, 2026 FORM 4
6-K Sep 14, 2026 6-K
6-K Sep 2, 2026 6-K
6-K Sep 1, 2026 6-K
6-K Aug 20, 2026 6-K
6-K Jul 21, 2026 6-K
6-K Jul 2, 2026 6-K
6-K May 21, 2026 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
3 May 18, 2026 FORM 3
3 May 18, 2026 FORM 3
3 May 18, 2026 FORM 3
4 May 6, 2026 FORM 4
6-K Apr 23, 2026 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Apr 21, 2026 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Apr 20, 2026 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Apr 14, 2026 6-K
6-K Apr 14, 2026 6-K
6-K Apr 13, 2026 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Apr 10, 2026 6-K
6-K Apr 9, 2026 6-K
6-K Apr 7, 2026 6-K
6-K Apr 2, 2026 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
4 Apr 1, 2026 FORM 4
3 Apr 1, 2026 FORM 3
3 Apr 1, 2026 FORM 3
← Newer Page 1 of 5 · 102 filings Older →